Skip to main content

What the FDA labels say about taking them together

Bempedoic acid and cyclosporine

Neither FDA label names the other in its interaction, contraindication or warning sections. A label lists the interactions its studies and reports found; it is not a complete list, so ask a pharmacist before combining medicines. Labels read October 8, 2026.

Check it at the source: the bempedoic acid FDA label on DailyMed (effective June 25, 2026, Esperion Therapeutics, Inc.); the cyclosporine FDA label on DailyMed (effective August 10, 2026, Novartis Pharmaceuticals Corporation).

What does the bempedoic acid label say about cyclosporine?

Bempedoic acid's label (effective June 25, 2026) does not name cyclosporine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Nexletol), Esperion Therapeutics, Inc., effective June 25, 2026 (SPL set 88d06d89-a3da-40b4-b273-8f4f7d56c4c9), via openFDA; the full label on DailyMed

What does the cyclosporine label say about bempedoic acid?

Cyclosporine's label (effective August 10, 2026) and its 3 other brand-application labels do not name bempedoic acid in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Neoral), Novartis Pharmaceuticals Corporation, effective August 10, 2026 (SPL set 94461af3-11f1-4670-95d4-2965b9538ae3), via openFDA; the full label on DailyMed

A pharmacist or prescriber can say whether these two medicines suit one person together; PlainMeds does not grade interactions.

Both medicines on the record

0Bempedoic acid generic labelers
14Cyclosporine generic labelers
Bempedoic acidCyclosporine
Labeled forHeart attack and coronary artery disease, High cholesterolOrgan transplant rejection, Rheumatoid arthritis
Boxed warningNoYes
Pharmacy cost (NADAC)$13.81 per tablet 180 mg tablet$1.04 per unit 0.05% eye emulsion
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?